The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B
Open accessAbstract
During the course of chronic hepatitis B virus (HBV) infection, hepatitis B e antigen (HBeAg) seroconversion to its antibody (anti-HBe) often coincides with normalization of liver biochemical test and clinical remission, but data regarding long-term outcome after spontaneous seroconversion are still scarce. Excluding patients with other virus(es) concurrent infection, 283 patients with chronic HBV infection were followed up for at least 1 year after spontaneous HBeAg seroconversion to anti-HBe. Follow-up studies included clinical, biochemical, and virologic evaluation and hepatocellular carcinoma (HCC) screening with ultrasonography and α-fetoprotein assay. During a median follow-up period of 8.6 years (range, 1 to 18.4 years) after HBeAg seroconversion in 283 patients, 189 (66.8%) showed sustained remission, whereas the remaining 94 (33.2%) experienced alanine aminotransferase (ALT) elevation over twice the upper limit of normal: 12 (4.2%) associated with HBeAg reversion, 68 (24%) with detectable serum HBV DNA but HBeAg negative, and 14 (4.9%) of undetermined causes. Of the 269 patients without evidence of cirrhosis at the time of HBeAg seroconversion, 21 (7.8%) developed cirrhosis with a cumulative incidence and relative risk significantly higher in patients developing active hepatitis than in patients with sustained remission (P < .05). HCC developed in 6 (2.2%) of the 283 patients, also with a significantly higher cumulative incidence in patients developing active hepatitis after HBeAg seroconversion (P < .005). In conclusion, the results suggest that spontaneous HBeAg seroconversion confers favorable long-term outcomes. However, active hepatitis still may develop and lead to cirrhosis and HCC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Carman, W. F., Hadziyannis, S., Mcgarvey, M. J., Jacyna, M. R., Karayiannis, P., Makris, A., & Thomas, H. C. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90713-7 · Cited by 1,200
Long-Term Follow-up of HBeAg-Positive Patients Treated with Interferon Alfa for Chronic Hepatitis B
Niederau, C., Heintges, T., Lange, S., Goldmann, G., Niederau, C. M., Mohr, L., & Häussinger, D. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605303342202 · Cited by 803
The development of cirrhosis in patients with chronic type B hepatitis: A prospective study
Liaw, Y.-F., Tai, D.-I., Chu, C.-M., & Chen, T.-J. (1988) · Hepatology · doi:10.1002/hep.1840080310 · Cited by 612
Self-citationLin, S.-M., Sheen, I.-S., Chien, R.-N., Chu, C.-M., & Liaw, Y.-F. (1999) · Hepatology · doi:10.1002/hep.510290312 · Cited by 444
Self-citationChu, C.-M., Karayiannis, P., Fowler, M. J. F., Monjardino, J., Liaw, Y.-F., & Thomas, H. C. (1985) · Hepatology · doi:10.1002/hep.1840050315 · Cited by 419
Self-citationLiaw, Y.-F., Chu, C.-M., Su, I.-J., Huang, M.-J., Lin, D.-Y., & Chang-Chien, C.-S. (1983) · Gastroenterology · doi:10.1016/s0016-5085(83)80114-0 · Cited by 341
Self-citationEarly detection of hepatocellular carcinoma in patients with chronic type B hepatitis
Liaw, Y.-F., Tai, D.-I., Chu, C.-M., Lin, D.-Y., Sheen, I.-S., Chen, T.-J., & Pao, C. C. (1986) · Gastroenterology · doi:10.1016/0016-5085(86)90919-4 · Cited by 309
Self-citationLiaw, Y.-F., Sheen, I.-S., Chen, T.-J., Chu, C.-M., & Pao, C.-C. (1991) · Hepatology · doi:10.1002/hep.1840130403 · Cited by 294
Self-citationSpontaneous reactivation of chronic hepatitis B virus infection
Davis, G. L., Hoofnagle, J. H., & Waggoner, J. G. (1984) · Gastroenterology · doi:10.1016/0016-5085(84)90406-2 · Cited by 288
Ultrasonographic changes of early liver cirrhosis in chronic hepatitis B: A longitudinal study
Lin, D., Sheen, I., Chiu, C., Lin, S., Kuo, Y., & Liaw, Y. (1993) · Journal of Clinical Ultrasound · doi:10.1002/jcu.1870210502 · Cited by 170
Self-citation
Cited by
Management of Hepatocellular Carcinoma *
Bruix, J., & Sherman, M. (2005) · Hepatology · doi:10.1002/hep.20933 · Cited by 5,857
Lok, A. S. F., & McMahon, B. J. (2007) · Hepatology · doi:10.1002/hep.21513 · Cited by 3,087
Chronic hepatitis B: Update 2009 #
Lok, A. S. F., & McMahon, B. J. (2009) · Hepatology · doi:10.1002/hep.23190 · Cited by 2,831
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
Fattovich, G., Stroffolini, T., Zagni, I., & Donato, F. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.014 · Cited by 2,591
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
Sarin, S. K., Kumar, M., Lau, G. K., Abbas, Z., Chan, H. L. Y., Chen, C. J., Chen, D. S., Chen, H. L., Chen, P. J., Chien, R. N., et al. (2016) · Hepatology International · doi:10.1007/s12072-015-9675-4 · Cited by 2,550
Self-citationLamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease
Liaw, Y.-F., Sung, J. J. Y., Chow, W. C., Farrell, G., Lee, C.-Z., Yuen, H., Tanwandee, T., Tao, Q.-M., Shue, K., Keene, O. N., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033364 · Cited by 2,266
Self-citationPredicting Cirrhosis Risk Based on the Level of Circulating Hepatitis B Viral Load
Iloeje, U. H., Yang, H., Su, J., Jen, C., You, S., & Chen, C. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.016 · Cited by 1,528
Fattovich, G., Bortolotti, F., & Donato, F. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2007.11.011 · Cited by 1,348
Liaw, Y.-F., & Chu, C.-M. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60207-5 · Cited by 1,218
Self-citationAsian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update
Liaw, Y.-F., Kao, J.-H., Piratvisuth, T., Chan, H. L. Y., Chien, R.-N., Liu, C.-J., Gane, E., Locarnini, S., Lim, S.-G., Han, K.-H., et al. (2012) · Hepatology International · doi:10.1007/s12072-012-9365-4 · Cited by 1,038
Self-citationThe natural history of chronic hepatitis B virus infection #
McMahon, B. J. (2009) · Hepatology · doi:10.1002/hep.22898 · Cited by 876
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update
Liaw, Y.-F., Leung, N., Kao, J.-H., Piratvisuth, T., Gane, E., Han, K.-H., Guan, R., Lau, G. K. K., Locarnini, S., & for the Chronic Hepatitis B Guideline Working Party of the Asian-Pacific Association for the Study of the Liver (2008) · Hepatology International · doi:10.1007/s12072-008-9080-3 · Cited by 867
Self-citationChronic Hepatitis B Infection: A Review
Tang, L. S. Y., Covert, E., Wilson, E., & Kottilil, S. (2018) · JAMA · doi:10.1001/jama.2018.3795 · Cited by 657
Global burden of hepatitis B virus: current status, missed opportunities and a call for action
Hsu, Y.-C., Huang, D. Q., & Nguyen, M. H. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00760-9 · Cited by 632
Self-citationManagement of hepatitis B: Summary of a clinical research workshop†
Hoofnagle, J. H., Doo, E., Liang, T. J., Fleischer, R., & Lok, A. S. F. (2007) · Hepatology · doi:10.1002/hep.21627 · Cited by 628
Hepatitis B Virus Genotype and DNA Level and Hepatocellular Carcinoma: A Prospective Study in Men
Yu, M.-W., Yeh, S.-H., Chen, P.-J., Liaw, Y.-F., Lin, C.-L., Liu, C.-J., Shih, W.-L., Kao, J.-H., Chen, D.-S., & Chen, C.-J. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji043 · Cited by 569
Self-citationJeng, W.-J., Papatheodoridis, G. V., & Lok, A. S. F. (2023) · The Lancet · doi:10.1016/s0140-6736(22)01468-4 · Cited by 561
Keeffe, E. B., Dieterich, D. T., Han, S.-H. B., Jacobson, I. M., Martin, P., Schiff, E. R., & Tobias, H. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.08.021 · Cited by 558
Yim, H. J., & Lok, A. S.-F. (2006) · Hepatology · doi:10.1002/hep.20956 · Cited by 545
EASL INTERNATIONAL CONSENSUS CONFERENCE ON HEPATITIS B
Jury, T. E. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00378-7 · Cited by 512
Shouval, D. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00152-1 · Cited by 470
Soriano, V., Sulkowski, M., Bergin, C., Hatzakis, A., Cacoub, P., Katlama, C., Cargnel, A., Mauss, S., Dieterich, D., Moreno, S., et al. (2002) · AIDS · doi:10.1097/00002030-200204120-00001 · Cited by 444
EASL Clinical Practice Guidelines on the management of hepatitis B virus infection
Cornberg, M., Sandmann, L., Jaroszewicz, J., Kennedy, P., Lampertico, P., Lemoine, M., Lens, S., Testoni, B., Lai-Hung Wong, G., & Russo, F. P. (2025) · Journal of Hepatology · doi:10.1016/j.jhep.2025.03.018 · Cited by 437
Sánchez-Tapias, J. M., Costa, J., Mas, A., Bruguera, M., & Rodés, J. (2002) · Gastroenterology · doi:10.1053/gast.2002.37041 · Cited by 415
Kumar, M., Sarin, S. K., Hissar, S., Pande, C., Sakhuja, P., Sharma, B. C., Chauhan, R., & Bose, S. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.02.075 · Cited by 401
Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications
Yuen, M.-F., Yuan, H.-J., Wong, D. K.-H., Yuen, J. C.-H., Wong, W.-M., Chan, A. O.-O., Wong, B. C.-Y., Lai, K.-C., & Lai, C.-L. (2005) · Gut · doi:10.1136/gut.2005.065136 · Cited by 375
Keeffe, E. B., Dieterich, D. T., Han, S. B., Jacobson, I. M., Martin, P., Schiff, E. R., Tobias, H., & Wright, T. L. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.05.016 · Cited by 374
A treatment algorithm for the management of chronic hepatitis B virus infection in the United States
Keeffe, E. B., Dieterich, D. T., Han, S.-H. B., Jacobson, I. M., Martin, P., Schiff, E. R., Tobias, H., & Wright, T. L. (2004) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(03)00312-4 · Cited by 359
Marcellin, P., Chang, T.-T., Lim, S. G. L., Sievert, W., Tong, M., Arterburn, S., Borroto-Esoda, K., Frederick, D., & Rousseau, F. (2008) · Hepatology · doi:10.1002/hep.22414 · Cited by 306
Chan, H. L.-Y., Tse, C.-H., Mo, F., Koh, J., Wong, V. W.-S., Wong, G. L.-H., Lam Chan, S., Yeo, W., Sung, J. J.-Y., & Mok, T. S.-K. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.2043 · Cited by 301
Hepatitis B flares in chronic hepatitis B: Pathogenesis, natural course, and management
Chang, M.-L., & Liaw, Y.-F. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.08.033 · Cited by 296
Self-citationGuideline of Prevention and Treatment for Chronic Hepatitis B (2015 Update)
Hou, J., Wang, G., Wang, F., Cheng, J., Ren, H., Zhuang, H., Sun, J., Li, L., Li, J., Meng, Q., et al. (2017) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2016.00019 · Cited by 270
Gish, R. G., Given, B. D., Lai, C.-L., Locarnini, S. A., Lau, J. Y. N., Lewis, D. L., & Schluep, T. (2015) · Antiviral Research · doi:10.1016/j.antiviral.2015.06.008 · Cited by 259
Tseng, T.-C., Liu, C.-J., Yang, H.-C., Su, T.-H., Wang, C.-C., Chen, C.-L., Hsu, C.-A., Kuo, S. F.-T., Liu, C.-H., Chen, P.-J., et al. (2013) · Hepatology · doi:10.1002/hep.26041 · Cited by 258
The cost-effectiveness of screening for chronic hepatitis B infection in the United States
Eckman, M. H., Kaiser, T. E., & Sherman, K. E. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir199 · Cited by 80
Ghozy, S., Nam, N. H., Radwan, I., Karimzadeh, S., Tieu, T. M., Hashan, M. R., Abbas, A. S., Eid, P. S., Vuong, N. L., Khang, N. V., et al. (2020) · Reviews in Medical Virology · doi:10.1002/rmv.2089 · Cited by 32
Mortality from cirrhosis: lack of progress over the last 35 years
Gluud, C. (2005) · Gut · doi:10.1136/gut.2005.072876 · Cited by 17
Jang, T.-Y., Ho, C.-C., Wu, C.-D., Dai, C.-Y., & Chen, P.-C. (2023) · Medicine · doi:10.1097/md.0000000000034276 · Cited by 10
Metadata
- Authors
- Hsu, Y.-S., Chien, R.-N., Yeh, C.-T., Sheen, I.-S., Chiou, H.-Y., Chu, C.-M., & Liaw, Y.-F.
- Venue
- Hepatology
- Published
- 2002-06
- Volume
- 35
- Issue
- 6
- Pages
- 1522-1527
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W1982812988
- Cited by
- 705
- References
- 12
- FWCI
- 19.25
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.